CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Open-market sale CEO sold 22,300 shares at an average $84.94 ($1,894,125)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise President & CSO acquired 3,731 shares (option exercise)
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 4 Option exercise CFO acquired 7,309 shares (option exercise)
- DRS Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- 4 Option exercise CEO acquired 115,000 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Other acquisition 10% owner acquired 356,674 shares (other)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 23 of 26 · 514 filings